I think there should be a viable plan B for you shareholders. You may disagree with me, but in the end, we both want what is best for the shareholders. Success for the shareholders means success for the SCD patients.
I just disagree with going forward with a company that has a bad reputation and loads of debt. There can be another way. If Monte is making good inroads and if Pandey is not a part of it, then why bother using the XN in name? seems to me this is baggage we don't need.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.